A podiatrist in Georgia heard this from a patient with a severe heel infection. Many patients at this wound care clinic were already reluctant to check into a hospital for a several-day stay to receive a series of IV treatments. But now during the COVID-19 pandemic, patients are refusing. This patient’s infection was so severe that the physician needed to start treatment immediately to reduce the infection and quickly schedule surgery.

“For a case like this, the standard of care used to be to admit the patient to the hospital or they might refer them to the infusion center for daily infusions if the patient is likely to be compliant,” said Joe O’Weger, key account manager in Atlanta, Georgia. “But, the standard of care is rapidly changing. With COVID-19, patients don’t want to go to the hospitals, and oftentimes, the hospitals don’t even have room for them.”

Following the traditional standard of care, the podiatrist called the hospital where he would place this patient for treatment. But, even if the patient was compliant with hospital admittance, there wasn’t space for him. The physician needed a treatment that would be fast-acting, effective and administered without a hospital to ensure compliance. That’s when he considered our therapeutic.